Evidence map›Paper›PMID 42814746›Full record

ArticlePloS one2026

A lethal ORC ATPase mutation is suppressed by alterations in ORC and RNA Pol II transcription components.

Luis E Martínez-Rodríguez, Stephen P Bell

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Luis E Martínez-RodríguezDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA, United States of America.ORCID https://orcid.org/0009-0009-5749-7998
Stephen P BellDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA, United States of America.ORCID https://orcid.org/0000-0002-2876-610X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The origin recognition complex (ORC) binds origins of replication and directs the loading of the Mcm2-7 replicative helicase at these sites. Five of the six ORC subunits are related to the AAA+ family of ATPases. Although functions for ATP hydrolysis by Cdc6 and the Mcm2-7 complex have been described, the essential role of ORC ATP hydrolysis remains unclear. We performed a genetic screen in Saccharomyces cerevisiae for suppressors of the lethal phenotype of the orc4-R267A allele, which disrupts ORC ATP hydrolysis in vitro. We identified six causative mutations, five of which are distributed across different ORC subunits. The suppressor mutations in Orc1 and Orc4, but not those in other ORC subunits, increase the in vitro helicase loading activity of ATPase-defective ORC (ORC4R). Allele specificity studies show the alleles specifically suppress defects at ATPase interfaces within the ORC-Cdc6 complex. The sixth allele is a mutation in TOA2, a subunit of the TFIIA general transcription factor. Mutations in the general transcription factors TBP and TFIIB, and the large subunit of RNA Polymerase II also suppress orc4-R267A lethality, suggesting that reducing transcription is sufficient for suppression. Our study identifies multiple pathways to suppress the lethal phenotype of an ATPase-defective ORC allele and reveals a connection between ORC ATP hydrolysis and transcription.

Indexed as

Adenosine TriphosphatasesMutationOrigin Recognition ComplexRNA Polymerase IISaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTranscription, GeneticAdenosine TriphosphateAllelesCell Cycle ProteinsHydrolysisAdenosine TriphosphatasesAdenosine TriphosphateCell Cycle ProteinsOrigin Recognition ComplexRNA Polymerase IISaccharomyces cerevisiae Proteins

Identifiers

PMID42814746
PMCPMC13626347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.